SlideShare a Scribd company logo
Your	Investment	Career	Advantage
September	1,	2015
Dear	Sankalp,
Zolio	wishes	to	thank	you	for	your	engagement	in	the	Zolio	Summer	2015	Investment
Management	program.
Having	successfully	completed	the	tasks	required	of	an	intern,	you	helped	us	understand	and
improve	Zolio	as	an	educational	platform	for	investment	management.	In	addition,	you	learned
the	basics	of	how	to	analyze	a	stock,	build	a	portfolio,	and	think	about	market	movements	and
your	trade	decisions	in	the	context	of	your	own	trading	strategy.
The	tasks	you	completed	for	Zolio	included:
Participating	in	the	Zolio	psychometric	profile	exercise
Learning	how	to	operate	the	Zolio	trading	platform	and	build	a	portfolio	of	equities	and
ETFs
Accessing	and	commenting	on	the	Learning	Center	materials
Familiarizing	yourself	with	the	user	experience	of	being	a	Zolio	participant	in	order	to
respond	to	a	user	survey
Attending	multiple	webinars	for	which	preparatory	work	was	done	ahead	of	time
In	the	event	future	employers	wish	to	verify	your	participation	in	the	Zolio	internship	program,
they	may	reach	us	as	follows:
Zolio,	Inc.
1001	Avenue	of	the	Americas
New	York,	NY	10018
Email:	support@zolio.com
Attention:	Anna	Schuchmann
Tel:	212.403.2840
Again,	thank	you	for	your	participation	and	for	helping	us	improve	our	trading	platform	and
learning	experience.
Regards,
Olive	M.	Darragh
Zolio,	CEO	and	Founder
www.zolio.com
Report	for	Sankalp	Krishnan
June	01,	2015	-	August	08,	2015	(Certified	by	Zolio)
Starting	Capital $1,000,000 	 Net	P&L $7,132
Ending	Capital $1,007,132 	 Trading	P&L $8,317
Net	RoR 0.71% 	 Commissions ($975)
Trading	RoR 0.83% 	 Borrow	Costs ($210)
Trading	Days 49 	 Executed	Trades 193
Distinct	Instruments	Traded 67 	 	 	
Continued...
RoR
Sankalp	Krishnan	vs.	Market	Benchmarks
Sankalp	(+0.71%) S&P	500	(-1.42%) Dow	(-3.54%) NASDAQ	(-0.52%)
8.	Jun 22.	Jun 6.	Jul 20.	Jul 3.	Aug
0
-5
-2.5
2.5
5
P&L	(USD)
Sankalp	Krishnan	Daily	P&L
8.	Jun 22.	Jun 6.	Jul 20.	Jul 3.	Aug
-20k
0k
20k
40k
By	Type By	Direction By	Status
Zolio	Performance	Report	for	Sankalp	Krishnan	(continued)
Monthly	Performance
Period PnL RoR S&P Dow NASDAQ
Jun.	01-30	2015 (6,617) -0.66% -2.10% -2.17% -1.64%
Jul.	01-31	2015 19,664 1.98% 1.97% 0.40% 2.84%
Aug.	01-07	2015 (5,915) -0.58% -1.25% -1.79% -1.65%
Wins	/	Losses
Top	5	Losing	Days Top	5	Winning	Days
2015-07-24 (14,850) -1.46% 2015-07-16 25,468 2.54%
2015-07-08 (9,620) -0.97% 2015-08-05 10,211 1.01%
2015-06-29 (8,857) -0.88% 2015-07-28 7,984 0.80%
2015-08-06 (6,997) -0.69% 2015-07-10 6,102 0.62%
2015-07-02 (6,199) -0.62% 2015-07-13 5,921 0.60%
Top	5	Losing	Positions Top	5	Winning	Positions
CI (8,191) NFLX 24,363
ANTM (7,318) MO 7,081
BRKS (4,395) MSFT 2,781
HUM (4,244) LOCK 1,910
USO (3,904) SLB 1,893
Orders	/	Trades
Total	orders:	201			|			Filled	orders:	193			|			Avg.	orders/day:	4.1
This	performance	report	has	been	certified	by	Zolio,	an	independent	trading	platform	with	real-time	market	feeds.
Employers	should	feed	free	to	contact	Zolio	at	support@zolio.com	with	any	questions	or	for	further	clarification.
Market
Limit
Stop
Buy
Sell
Filled
Expired
Cancelled
Zolio	Profile	Report	for	Sankalp	Krishnan	(continued)
Portfolio	Overview
Below	are	all	positions	held	during	your	trading	experience.	Note	that	the	maximum	short	and	long	market	values
reflect	position	valuation	at	the	close	of	trading	and	might	not	reflect	intraday	position	or	pricing	changes.
Positions	where	neither	value	is	provided	reflect	a	position	that	was	opened	and	fully	liquidated	on	a	single	day.
Instrument Trades
Max	Long
Mkt.Value
Max	Short
Mkt.Value
P&L
Basic	materials $1,994
Schlumberger	Limited	(SLB) 6 — — $1,893
Seadrill	Limited	(SDRL) 2 — — $101
Consumer	goods $9,720
Altria	Group	Inc.	(MO) 3 $64,752 — $7,081
The	Clorox	Company	(CLX) 3 $32,210 — $1,879
Apple	Inc.	(AAPL) 3 $25,718 — ($1,602)
Archer	Daniels	Midland	Co.	(ADM) 2 $10,400 — ($712)
Kimberly-Clark	Corporation	(KMB) 2 $11,294 — $699
The	Hershey	Company	(HSY) 3 $37,144 — $594
Colgate-Palmolive	Co.	(CL) 3 $22,374 — $583
British	American	Tobacco	p.l.c.	(American
Depository	Receipts)	(BTI)
2 $7,756 — $564
Tyson	Foods	Inc.	(TSN) 2 $6,301 — $497
Estee	Lauder	Companies	Inc.	(EL) 2 $13,443 — $198
Diageo	plc	(DEO) 1 $22,790 — ($73)
General	Motors	Company	(GM) 2 — — $12
Financial ($2,696)
United	States	Oil	Fund,	LP	(USO) 8 $34,100 — ($3,904)
iPath	S&P	500	VIX	ST	Futures	ETN	(VXX) 43 — — $1,309
Central	Fund	of	Canada	Limited	(CEF) 1 $21,100 — ($249)
iShares	MSCI	United	Kingdom	Index	Fund	(EWU) 2 — — $61
Deutsche	Bank	AG	(DB) 2 — — $46
Market	Vectors	Gold	Miners	ETF	(GDX) 2 — — $42
Healthcare ($22,222)
CIGNA	Corporation	(CI) 3 $69,462 — ($8,191)
Anthem	Inc.	(ANTM) 3 $79,295 ($17,104) ($7,318)
Humana	Inc.	(HUM) 2 $84,348 — ($4,244)
Biogen	Inc.	(BIIB) 1 $16,703 — ($3,060)
Aetna	Inc.	(AET) 1 $19,508 — ($2,524)
WellCare	Health	Plans	Inc.	(WCG) 3 — ($43,710) $1,786
UnitedHealth	Group	Inc.	(UNH) 1 $94,395 — ($1,758)
Centene	Corporation	(CNC) 1 $12,135 — ($1,546)
Baxter	International	Inc.	(BAX) 2 $20,478 — $1,344
GlaxoSmithKline	(GSK) 2 $32,693 — $1,171
Valeant	Pharmaceuticals	International	Inc.
(VRX)
3 — ($46,790) $1,033
Molina	Healthcare	Inc.	(MOH) 2 $15,322 — $770
Abbott	Laboratories	(ABT) 2 $10,240 — $502
AstraZeneca	Group	plc	(AZN) 2 — ($20,367) ($500)
Allergan	Inc.	(AGN) 2 $32,698 — $214
Sanofi	(SNY) 2 — — $91
Teva	Pharma	Ind	Shs	Sponsored	American
Deposit	Receipt	Repr	1	Sh	(TEVA)
2 — — $6
Industrial	goods $10
General	Electric	Company	(GE) 4 — — $10
Services $18,228
Netflix	Inc.	(NFLX) 2 $141,522 — $24,363
The	Gap	Inc.	(GPS) 1 $29,415 — ($2,268)
McKesson	Corporation	(MCK) 1 $23,604 — ($2,013)
Bed	Bath	&	Beyond	Inc.	(BBBY) 1 $17,778 — ($1,564)
Best	Buy	Co.	(BBY) 1 $12,254 — ($1,192)
Nordstrom	Inc.	(JWN) 2 $11,928 — $825
Wendy's	Company	(The)	(WEN) 1 $10,110 — ($714)
Kohls	Corporation	(KSS) 2 $12,992 — ($603)
Lithia	Motors	Inc.	(LAD) 3 — ($176,580) $542
The	Walt	Disney	Company	(DIS) 5 $60,560 — $442
Kroger	Co.	(KR) 2 $7,834 — $414
DISH	Network	Corporation	(DISH) 1 $13,850 — ($279)
Etsy	Inc.	(ETSY) 2 — — $236
Macy's	Inc.	(M) 2 $14,560 — $40
Technology $2,098
Brooks	Automation,	Inc.	(BRKS) 2 $112,300 — ($4,395)
Microsoft	Corporation	(MSFT) 2 $47,540 — $2,781
LifeLock	Inc.	(LOCK) 2 $80,500 — $1,910
Arista	Networks	(ANET) 3 — — $1,352
Akamai	Technologies	Inc.	(AKAM) 1 — ($15,342) ($1,288)
NeuStar	Inc.	(NSR) 4 — — $1,280
AT&T	Inc.	(T) 1 $69,320 — ($1,269)
Imperva	Inc.	(IMPV) 3 — — ($915)
Axcelis	Technologies,	Inc.	(ACLS) 3 — ($16,050) $728
International	Business	Machines	Corporation
(IBM)
2 — — $561
RingCentral	Inc.	(RNG) 2 — — $522
Intel	Corporation	(INTC) 2 — — $455
Google	Inc.	(GOOGL) 2 — — $263
Verizon	Communications	(VZ) 4 $9,334 — $230
KLA	-	Tencor	Corporation	(KLAC) 2 $31,830 — ($119)
Zolio	Profile	Report	for	Sankalp	Krishnan	(continued)
Trading	Style	Comparison
These	comparisons	show	core	metrics	for	your	account	versus	the	average	values	of	your	intern	class.
Metric Sankalp	Krishnan Summer	2015	(Avg)
Overall	Performance
Rate	of	Return +0.71% -0.61%
P&L $7,132 ($6,124)
Trades	and	Executions
Number	of	Trades 193 47
Avg	Trade	Market	Value $38,179 $52,282
Distinct	Instruments	Traded	* 67 22
Avg	Trade	Confidence 65 66
Average	Daily	Market	Values
Long	Portfolio $547,732 $377,636
Short	Portfolio ($38,017) ($43,286)
Available	Buying	Power $524,437 $671,579
Journaling	&	Engagement
Weekly	Journals	** 8 7.9
Trade	Journals 194 39.8
Percent	of	Trades	Journaled 96% 74%
*	To	be	in	compliance	with	Zolio	trading	rules,	participants	must	trade	at	least	ten	distinct	instruments.
**	Participants	must	submit	weekly	journal	entries	to	continue	trading	on	the	platform.
This	performance	report	has	been	certified	by	Zolio,	an	independent	trading	platform	with	real-time	market	feeds.
Employers	should	feed	free	to	contact	Zolio	at	support@zolio.com	with	any	questions	or	for	further	clarification.
Zolio	Performance	Report	for	Sankalp	Krishnan	(continued)
Zolio	Experiences,	Strengths,	and	Preferences	(Zolio	ESP™)
At	the	start	of	your	Zolio	experience,	we	asked	you	to	complete	an	initial	survey	with	many	questions	about	your
experiences,	strengths,	and	preferences	(Zolio	ESP™).	This	section	of	your	report	is	meant	to	provide	you	with
feedback	about	those	Zolio	ESP™	results	which	are	linked	to	your	personality	and	behavior.
With	extensive	investing	experience	on	Zolio's	platform	we	endeavor	to	highlight	the	correlation	between	your
Zolio	ESP™	profile	answers	and	your	trading	performance.	The	more	data	we	have,	the	more	accurate	the
correlations.	However,	with	a	relatively	short	trading	history,	correlations	are	unlikely	to	emerge	or	be
accurate.	Thus	your	Zolio	ESP™	feedback	focuses	only	on	how	you	answered	the	questions	relative	to
your	peers.
Here	are	a	few	important	things	to	remember	about	your	results:
1.	 There	is	no	"right"	or	"best"	or	"bad"	set	of	Zolio	ESP™	results.	The	results	are	about	you	and	your
talent	as	it	played	out	in	the	Zolio	process.
2.	 You	can	be	successful,	or	not,	using	any	set	of	personal	strengths	and	styles.	The	key	is	understanding
your	personal	strengths	and	style.	Zolio	ESP™	may	help	you	achieve	that	by	looking	at	how	you
answered	the	questions	relative	to	your	peers.
3.	 You	may	believe	that	your	talents	and	style	"really"	are	different	from	your	Zolio	ESP™	results.	That	could
be	due	to	some	or	all	of	the	following	factors:
You	might	think	of	yourself	personally	being	one	way,	but	you	answered	the	questions	on	the	Zolio
ESP™	in	a	different	way.
You	thought	some	of	the	questions	were	just	plain	odd	and	you	weren't	sure	what	was	being	asked.	If
you	had	understood	them	differently	you	might	have	responded	differently.
Maybe	you	tried	to	game	the	items	(i.e.	thought	there	were	"right"	answers)	and	if	so	these	results
reflect	how	you	seem	while	trying	to	guess	right	answers	rather	than	how	you	truly	are.
4.	 Your	Zolio	ESP™	results	may	be	more	accurate	than	you	think	they	are.	Consider	what	you	would	be	like	if
the	results	were	really	true;	how	do	your	experiences,	strengths,	and	preferences	contribute	to	your
success	or	developmental	needs?	Take	whatever	the	outcomes	and	feedback	tell	you,	and	work	with	them
to	build	yourself	as	an	investor	and	trader.
Continued...
Zolio	Performance	Report	for	Sankalp	Krishnan	(continued)
Benchmarking	your	results
Extensive	research	by	Zolio	and	many	others	in	the	investment	world	indicate	that	successful	investors	have	a
broad	range	of	talents	and	traits.	Zolio	focuses	on	a	few	that	are	consistently	seen	as	correlated	with	success	as
an	investor.	These	traits	and	talents	can	be	combined	in	many	ways.	There	are	few,	if	any	investors,	who	are
equally	strong	across	all	talents	and	traits.	Your	feedback	report	indicates	how	you	scored	on	the	Zolio	ESP™
relative	to	your	peers	in	terms	of	these	talents	and	traits.
Financial	analytical	ability	and	market	savvy:	successful	investors	are	highly	analytical.	They	are
swayed	by	logic,	facts,	and	evidence.
Self-management:	successful	investors	are	highly	goal-oriented	and	disciplined.	They	use	their	trading
results	to	keep	score	not	only	relative	to	other	investors,	but	relative	to	their	own	goals.	These	investors
have	not	only	an	overall	trading	plan	for	their	portfolio,	but	have	one	for	individual	trades	as	well.	The	best
investors,	at	times,	lose	money,	but	unlike	others	they	have	two	responses	to	losing	money:	first,	they
relentlessly	analyze	their	trading	plans	and	execution	so	as	to	not	repeat	their	mistake,	and	second	they
systematically	work	their	way	back	from	losses	in	accordance	with	their	trading	plans.
Openness	to	new	experience:	successful	investors	are	always	looking	for	new	investing	ideas	even	in
well-defined	market	segments.	They	are	always	questioning	their	trading	ideas	and	seeking	feedback	from
trusted	sources.	These	investors	also	filter	out	sources	that	are	untrustworthy	or	unfruitful.	In	a	world
where	new	trading	opportunities	are	constantly	being	marketed,	it’s	important	for	these	traders	to	be
open	to	opportunities	but	be	prudent	with	their	sources	by	filtering	out	noise,	hearsay	and	information
that	is	not	fact-based.
Emotional	self-regulation	and	capacity	for	risk	tolerance:	successful	investors	are	able	to	function	in
the	face	of	adversity	or	elation	without	losing	their	perspective.	They	channel	their	emotional	energy	into
the	"rage	to	master"	rather	than	raging	against	adversity.	They	define	first	what	levels	of	returns	they	wish
to	achieve,	and	then	define	what	level	of	risk	they	are	willing	to	take	to	achieve	those	returns.	Return
targets	may	be	tempered	by	the	investor’s	capacity	to	manage	unease	about	risk.
The	chart	above	show	your	Zolio	ESP™	results	relative	to	Zolio	participants	whose	P&L	performance	was	in	the	top	quartile.	The	scores	are	reported	using	a	"T-
scale	score,"	which	is	a	scale	with	an	average	value	of	50	and	a	standard	deviation	of	10.	Thus,	a	score	of	50	is	average	relative	to	others,	a	score	of	60	is	higher	than
84%	of	all	others,	and	a	score	of	40	is	higher	than	16%	of	all	others.
T-scale	score
Sankalp	Krishnan	Zolio	ESP	Performance
52
42
47 4950 49 49 50 Sankalp	Krishnan
Zolio	Traders
(top	quartile)
Financial
Analytical	Ability
&	Market	Savvy
Self-Management Openness Self	Regulation
and	Risk
Tolerance
0
25
50
75
100

More Related Content

Similar to Zolio_Krishnan_Sankalp

VC Fundraising Q2 2005
  	VC Fundraising Q2 2005   	VC Fundraising Q2 2005
VC Fundraising Q2 2005
mensa25
 
NEW BROCHURE.31.7.2016
NEW BROCHURE.31.7.2016NEW BROCHURE.31.7.2016
NEW BROCHURE.31.7.2016
June Wegerle
 
aetna Download Documentation Financial Supplement 2005 3rd
aetna Download Documentation	Financial Supplement 2005 3rdaetna Download Documentation	Financial Supplement 2005 3rd
aetna Download Documentation Financial Supplement 2005 3rd
finance9
 
aetna Download Documentation Financial Supplement 2005 4th
aetna Download Documentation	Financial Supplement 2005 4thaetna Download Documentation	Financial Supplement 2005 4th
aetna Download Documentation Financial Supplement 2005 4th
finance9
 
aetna Download Documentation Financial Supplement 2005 2nd
aetna Download Documentation	Financial Supplement 2005 2ndaetna Download Documentation	Financial Supplement 2005 2nd
aetna Download Documentation Financial Supplement 2005 2nd
finance9
 

Similar to Zolio_Krishnan_Sankalp (20)

Mutual fund monthly review 06 2013
Mutual fund monthly review 06 2013Mutual fund monthly review 06 2013
Mutual fund monthly review 06 2013
 
July 2016 Zynex Investor Presentation
July 2016 Zynex Investor PresentationJuly 2016 Zynex Investor Presentation
July 2016 Zynex Investor Presentation
 
Optr 04052011
Optr 04052011Optr 04052011
Optr 04052011
 
Full Analyst Report: IntelGenx Tech. Rating: Buy. IntelGenx Looking Towards A...
Full Analyst Report: IntelGenx Tech. Rating: Buy. IntelGenx Looking Towards A...Full Analyst Report: IntelGenx Tech. Rating: Buy. IntelGenx Looking Towards A...
Full Analyst Report: IntelGenx Tech. Rating: Buy. IntelGenx Looking Towards A...
 
William Link, Versant Ventures
William Link, Versant VenturesWilliam Link, Versant Ventures
William Link, Versant Ventures
 
09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda09 CeoMeeting- Session 5- Abunda
09 CeoMeeting- Session 5- Abunda
 
Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015
 
Apollo investor presentation_june_2013
Apollo investor presentation_june_2013Apollo investor presentation_june_2013
Apollo investor presentation_june_2013
 
Epic research's weekly derivative market report 11th july 2016
Epic research's weekly derivative market report 11th july 2016Epic research's weekly derivative market report 11th july 2016
Epic research's weekly derivative market report 11th july 2016
 
Oxys stonegate deck august 2014 redchip
Oxys stonegate deck august 2014 redchipOxys stonegate deck august 2014 redchip
Oxys stonegate deck august 2014 redchip
 
Mercer Capital's Value Focus: Medical Technology | Year-End 2015
Mercer Capital's Value Focus: Medical Technology | Year-End 2015Mercer Capital's Value Focus: Medical Technology | Year-End 2015
Mercer Capital's Value Focus: Medical Technology | Year-End 2015
 
VC Fundraising Q2 2005
  	VC Fundraising Q2 2005   	VC Fundraising Q2 2005
VC Fundraising Q2 2005
 
Stryker Financial Analysis
Stryker Financial AnalysisStryker Financial Analysis
Stryker Financial Analysis
 
NEW BROCHURE.31.7.2016
NEW BROCHURE.31.7.2016NEW BROCHURE.31.7.2016
NEW BROCHURE.31.7.2016
 
Q22015 earnings deck final
Q22015 earnings deck finalQ22015 earnings deck final
Q22015 earnings deck final
 
Q22015 earnings deck final august 11 revised
Q22015 earnings deck final august 11 revisedQ22015 earnings deck final august 11 revised
Q22015 earnings deck final august 11 revised
 
Epic research weekly derivative report 10 august 2015
Epic research weekly derivative report 10 august 2015Epic research weekly derivative report 10 august 2015
Epic research weekly derivative report 10 august 2015
 
aetna Download Documentation Financial Supplement 2005 3rd
aetna Download Documentation	Financial Supplement 2005 3rdaetna Download Documentation	Financial Supplement 2005 3rd
aetna Download Documentation Financial Supplement 2005 3rd
 
aetna Download Documentation Financial Supplement 2005 4th
aetna Download Documentation	Financial Supplement 2005 4thaetna Download Documentation	Financial Supplement 2005 4th
aetna Download Documentation Financial Supplement 2005 4th
 
aetna Download Documentation Financial Supplement 2005 2nd
aetna Download Documentation	Financial Supplement 2005 2ndaetna Download Documentation	Financial Supplement 2005 2nd
aetna Download Documentation Financial Supplement 2005 2nd
 

Zolio_Krishnan_Sankalp